Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 115

1.

Randomized placebo-controlled study of low-dose warfarin for the prevention of central venous catheter-associated thrombosis in patients with cancer.

Couban S, Goodyear M, Burnell M, Dolan S, Wasi P, Barnes D, Macleod D, Burton E, Andreou P, Anderson DR.

J Clin Oncol. 2005 Jun 20;23(18):4063-9. Epub 2005 Mar 14.

PMID:
15767639
2.

Enoxaparin for the prevention of venous thromboembolism associated with central vein catheter: a double-blind, placebo-controlled, randomized study in cancer patients.

Verso M, Agnelli G, Bertoglio S, Di Somma FC, Paoletti F, Ageno W, Bazzan M, Parise P, Quintavalla R, Naglieri E, Santoro A, Imberti D, Sorarù M, Mosca S.

J Clin Oncol. 2005 Jun 20;23(18):4057-62. Epub 2005 Mar 14.

PMID:
15767643
3.

Prospective, randomized trial of two different modalities of flushing central venous catheters in pediatric patients with cancer.

Cesaro S, Tridello G, Cavaliere M, Magagna L, Gavin P, Cusinato R, Zadra N, Franco Zanon G, Zanesco L, Carli M.

J Clin Oncol. 2009 Apr 20;27(12):2059-65. doi: 10.1200/JCO.2008.19.4860. Epub 2009 Mar 9. Erratum in: J Clin Oncol. 2010 Feb 1;28(4):708.

PMID:
19273702
4.

Anticoagulation for thrombosis prophylaxis in cancer patients with central venous catheters.

Akl EA, Karmath G, Yosuico V, Kim SY, Barba M, Sperati F, Cook D, Schünemann HJ.

Cochrane Database Syst Rev. 2007 Jul 18;(3):CD006468. Review. Update in: Cochrane Database Syst Rev. 2011;(2):CD006468.

PMID:
17636845
5.

Risk factors for upper limb deep vein thrombosis associated with the use of central vein catheter in cancer patients.

Verso M, Agnelli G, Kamphuisen PW, Ageno W, Bazzan M, Lazzaro A, Paoletti F, Paciaroni M, Mosca S, Bertoglio S.

Intern Emerg Med. 2008 Jun;3(2):117-22. doi: 10.1007/s11739-008-0125-3. Epub 2008 Mar 4.

PMID:
18317868
6.

Systemic treatments for the prevention of venous thrombo-embolic events in paediatric cancer patients with tunnelled central venous catheters.

Schoot RA, Kremer LC, van de Wetering MD, van Ommen CH.

Cochrane Database Syst Rev. 2013 Sep 11;(9):CD009160. doi: 10.1002/14651858.CD009160.pub2. Review.

PMID:
24026801
7.

Warfarin thromboprophylaxis in cancer patients with central venous catheters (WARP): an open-label randomised trial.

Young AM, Billingham LJ, Begum G, Kerr DJ, Hughes AI, Rea DW, Shepherd S, Stanley A, Sweeney A, Wilde J, Wheatley K; WARP Collaborative Group, UK.

Lancet. 2009 Feb 14;373(9663):567-74. doi: 10.1016/S0140-6736(09)60205-1.

8.

Prevention of coagulase-negative staphylococcal central venous catheter-related infection using urokinase rinses: a randomized double-blind controlled trial in patients with hematologic malignancies.

van Rooden CJ, Schippers EF, Guiot HF, Barge RM, Hovens MM, van der Meer FJ, Rosendaal FR, Huisman MV.

J Clin Oncol. 2008 Jan 20;26(3):428-33. doi: 10.1200/JCO.2007.11.7754.

PMID:
18202420
9.

Dalteparin for prevention of catheter-related complications in cancer patients with central venous catheters: final results of a double-blind, placebo-controlled phase III trial.

Karthaus M, Kretzschmar A, Kröning H, Biakhov M, Irwin D, Marschner N, Slabber C, Fountzilas G, Garin A, Abecasis NG, Baronius W, Steger GG, Südhoff T, Giorgetti C, Reichardt P.

Ann Oncol. 2006 Feb;17(2):289-96. Epub 2005 Nov 29.

PMID:
16317012
10.
11.

Low-molecular-weight heparin (nadroparin) and very low doses of warfarin in the prevention of upper extremity thrombosis in cancer patients with indwelling long-term central venous catheters: a pilot randomized trial.

Mismetti P, Mille D, Laporte S, Charlet V, Buchmüller-Cordier A, Jacquin JP, Fournel P, Dutrey-Dupagne C, Decousus H; CIP Study Group.

Haematologica. 2003 Jan;88(1):67-73.

12.

Anticoagulation for people with cancer and central venous catheters.

Akl EA, Ramly EP, Kahale LA, Yosuico VE, Barba M, Sperati F, Cook D, Schünemann H.

Cochrane Database Syst Rev. 2014 Oct 15;(10):CD006468. doi: 10.1002/14651858.CD006468.pub5. Review.

PMID:
25318061
13.

Prophylaxis of central venous catheter-related thrombosis with minidose warfarin: analysis of its use in 427 cancer patients.

Magagnoli M, Masci G, Castagna L, Zucali PA, Morenghi E, Pedicini V, Santoro A.

Anticancer Res. 2005 Jul-Aug;25(4):3143-7.

14.
15.

Vitamin K antagonists in children with central venous catheter on chronic haemodialysis: a pilot study.

Paglialonga F, Artoni A, Braham S, Consolo S, Giannini A, Chidini G, Napolitano L, Martinelli I, Montini G, Edefonti A.

Pediatr Nephrol. 2016 May;31(5):827-32. doi: 10.1007/s00467-015-3293-1. Epub 2015 Dec 14.

PMID:
26667238
16.

Prevention of venous thromboembolic disease following primary total knee arthroplasty. A randomized, multicenter, open-label, parallel-group comparison of enoxaparin and warfarin.

Fitzgerald RH Jr, Spiro TE, Trowbridge AA, Gardiner GA Jr, Whitsett TL, O'Connell MB, Ohar JA, Young TR; Enoxaparin Clinical Trial Group.

J Bone Joint Surg Am. 2001 Jun;83-A(6):900-6.

PMID:
11407799
17.
19.

Low-intensity adjusted-dose warfarin for the prevention of hemodialysis catheter failure: a randomized, controlled trial.

Wilkieson TJ, Ingram AJ, Crowther MA, Soroka SD, Nagai R, Jindal KK, Clase CM.

Clin J Am Soc Nephrol. 2011 May;6(5):1018-24. doi: 10.2215/CJN.07240810. Epub 2011 Apr 14.

20.

Low-dose warfarin for the prevention of central line-associated thromboses in children with malignancies--a randomized, controlled study.

Ruud E, Holmstrøm H, De Lange C, Hogstad EM, Wesenberg F.

Acta Paediatr. 2006 Sep;95(9):1053-9.

PMID:
16938749

Supplemental Content

Support Center